Literature DB >> 33119791

Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review.

Barbara Bressi1,2, Maribel Cagliari3, Massimiliano Contesini4, Elisa Mazzini5, Franco Antonio Mario Bergamaschi6, Alfredo Moscato6, Maria Chiara Bassi7, Stefania Costi3,8.   

Abstract

PURPOSE: Androgen deprivation therapy (ADT) is a treatment used in men with prostate cancer (PCa); however it is responsible for many adverse effects, with negative impact on quality of life. ADT causes loss of bone mineral density (BMD) and skeletal muscle mass, alteration of body composition, and cognitive function, which altogether lead to increased risk of accidental falls and fractures. This systematic review analyses the effectiveness of physical exercise (PE) in preventing accidental falls and fractures and reducing the loss of BMD in men with PCa receiving ADT.
METHODS: We searched MEDLINE, EMBASE, CINAHL, and the Cochrane Library for articles between database inception and September 2, 2020. Eligible studies included randomized controlled trials (RCTs) investigating the effects of exercise on bone health in men with PCa receiving ADT.
RESULTS: Nine RCTs were included. Experimental PE consisted in multicomponent programmes that involved aerobic, resistance, impact-loading exercise, and football training. None of the RCTs investigated the risk of accidental falls and fractures, while two trials reported beneficial effects of PE on lumbar spine, hip, and femoral shaft BMD. No further significant difference was detected in the outcomes investigated.
CONCLUSION: Evidence of the effectiveness of PE to prevent the risk of accidental falls and fractures and BMD loss is lacking. Nevertheless, clinical guidelines recommend PE as a part of the clinical management of men with PCa receiving ADT due to its known numerous health benefits. Research should focus on PE strategies to prevent accidental falls, a clinically relevant outcome in this vulnerable population. TRIAL REGISTRATION: The study protocol was registered with International Prospective Register of Systematic Reviews (PROSPERO, number CRD 42020158444 ) on 04/28/2020.

Entities:  

Keywords:  Accidental falls; Exercise; Fractures, bone; Physical therapy modalities; Prevention; Prostatic neoplasms

Year:  2020        PMID: 33119791     DOI: 10.1007/s00520-020-05830-1

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  44 in total

Review 1.  Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.

Authors:  Heather L McGinty; Kristin M Phillips; Heather S L Jim; Julie M Cessna; Yasmin Asvat; Mallory G Cases; Brent J Small; Paul B Jacobsen
Journal:  Support Care Cancer       Date:  2014-05-25       Impact factor: 3.603

2.  The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy.

Authors:  Juan Morote; Antonio Gómez-Caamaño; José L Alvarez-Ossorio; Daniel Pesqueira; Angel Tabernero; Francisco Gómez Veiga; José A Lorente; Mariano Porras; Juan J Lobato; María J Ribal; Jacques Planas
Journal:  J Urol       Date:  2014-12-23       Impact factor: 7.450

3.  Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.

Authors:  Susan L Greenspan; Penelope Coates; Susan M Sereika; Joel B Nelson; Donald L Trump; Neil M Resnick
Journal:  J Clin Endocrinol Metab       Date:  2005-09-27       Impact factor: 5.958

4.  Prostate cancer, version 1.2014.

Authors:  James L Mohler; Philip W Kantoff; Andrew J Armstrong; Robert R Bahnson; Michael Cohen; Anthony Victor D'Amico; James A Eastham; Charles A Enke; Thomas A Farrington; Celestia S Higano; Eric Mark Horwitz; Mark H Kawachi; Michael Kuettel; Richard J Lee; Gary R Macvicar; Arnold W Malcolm; David Miller; Elizabeth R Plimack; Julio M Pow-Sang; Sylvia Richey; Mack Roach; Eric Rohren; Stan Rosenfeld; Eric J Small; Sandy Srinivas; Cy Stein; Seth A Strope; Jonathan Tward; Patrick C Walsh; Dorothy A Shead; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2013-12-01       Impact factor: 11.908

Review 5.  Cardiovascular events associated with androgen deprivation therapy in patients with prostate cancer: a systematic review and meta-analysis.

Authors:  Arie Carneiro; Andre Deeke Sasse; Andrew Aurel Wagner; Guilherme Peixoto; André Kataguiri; Ary Serpa Neto; Bianca Alves Vieira Bianco; Peter Chang; Antônio Carlos Lima Pompeo; Marcos Tobias-Machado
Journal:  World J Urol       Date:  2014-11-12       Impact factor: 4.226

6.  Mild cognitive impairment as a predictor of falls in community-dwelling older people.

Authors:  Kim Delbaere; Nicole A Kochan; Jacqueline C T Close; Jasmine C Menant; Daina L Sturnieks; Henry Brodaty; Perminder S Sachdev; Stephen R Lord
Journal:  Am J Geriatr Psychiatry       Date:  2012-10       Impact factor: 4.105

Review 7.  Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review.

Authors:  Shabbir M H Alibhai; Sven Gogov; Zishan Allibhai
Journal:  Crit Rev Oncol Hematol       Date:  2006-07-24       Impact factor: 6.312

8.  Risk of fracture after androgen deprivation for prostate cancer.

Authors:  Vahakn B Shahinian; Yong-Fang Kuo; Jean L Freeman; James S Goodwin
Journal:  N Engl J Med       Date:  2005-01-13       Impact factor: 91.245

9.  Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation.

Authors:  D A Galvão; D R Taaffe; N Spry; D Joseph; D Turner; R U Newton
Journal:  Prostate Cancer Prostatic Dis       Date:  2008-10-14       Impact factor: 5.554

Review 10.  The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis.

Authors:  Farhana Haseen; Liam J Murray; Chris R Cardwell; Joe M O'Sullivan; Marie M Cantwell
Journal:  J Cancer Surviv       Date:  2010-01-21       Impact factor: 4.442

View more
  7 in total

1.  Physical exercise habits, lifestyle behaviors, and motivation to change among men with prostate cancer: a cross-sectional study.

Authors:  Barbara Bressi; Cinzia Iotti; Maribel Cagliari; Stefania Fugazzaro; Silvio Cavuto; Franco Antonio Mario Bergamaschi; Alfredo Moscato; Stefania Costi
Journal:  Support Care Cancer       Date:  2022-02-22       Impact factor: 3.603

Review 2.  Exercise Adherence in Men with Prostate Cancer Undergoing Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis.

Authors:  Kellie Toohey; Maddison Hunter; Catherine Paterson; Reza Mortazavi; Benjamin Singh
Journal:  Cancers (Basel)       Date:  2022-05-16       Impact factor: 6.575

3.  Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial).

Authors:  Daniel A Galvão; Dennis R Taaffe; Dickon Hayne; Pedro Lopez; P Lyons-Wall; Colin I Tang; Suzanne K Chambers; Amanda Devine; Nigel Spry; Emily Jeffery; Christine Kudiarasu; David Joseph; Robert U Newton
Journal:  BMJ Open       Date:  2022-06-06       Impact factor: 3.006

4.  Feasibility and Safety of Physical Exercise to Preserve Bone Health in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: A Systematic Review.

Authors:  Maribel Cagliari; Barbara Bressi; Maria Chiara Bassi; Stefania Fugazzaro; Giuseppe Prati; Cinzia Iotti; Stefania Costi
Journal:  Phys Ther       Date:  2022-03-01

5.  Feasibility and safety of physical exercise in men with prostate cancer receiving androgen deprivation therapy and radiotherapy: a study protocol.

Authors:  Barbara Bressi; Cinzia Iotti; Maribel Cagliari; Silvio Cavuto; Stefania Fugazzaro; Stefania Costi
Journal:  BMJ Open       Date:  2022-03-15       Impact factor: 2.692

6.  Attitudes and adherence to changes in nutrition and physical activity following surgery for prostate cancer: a qualitative study.

Authors:  Richard M Martin; J Athene Lane; Luke A Robles; Ellie Shingler; Lucy McGeagh; Edward Rowe; Anthony Koupparis; Amit Bahl; Constance Shiridzinomwa; Raj Persad
Journal:  BMJ Open       Date:  2022-06-29       Impact factor: 3.006

7.  Bone loss induced by cancer treatments in breast and prostate cancer patients.

Authors:  Santos Castañeda; Ana Casas; Aránzazu González-Del-Alba; Guillermo Martínez-Díaz-Guerra; Xavier Nogués; Cristina Ojeda Thies; Óscar Torregrosa Suau; Álvaro Rodríguez-Lescure
Journal:  Clin Transl Oncol       Date:  2022-07-02       Impact factor: 3.340

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.